Quadrature Capital’s Sanara MedTech SMTI Stock Holding History

Quadrature Capital’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$175K	Buy	+10,172	New	+$209K	﹤0.01%	1148
2024 Q2	–	Sell	-6,616	Closed	-$244K	–	1507
2024 Q1	$244K	Sell	6,616 -236	-3%	-$8.82K	﹤0.01%	984
2023 Q4	$281K	Sell	6,852 -8,775	-56%	-$282K	0.01%	876
2023 Q3	$487K	Sell	15,627 -1,687	-10%	-$65.3K	0.01%	598
2023 Q2	$694K	Buy	17,314 +6,644	+62%	+$272K	0.02%	501
2023 Q1	$440K	Buy	10,670 +6,077	+132%	+$256K	0.01%	586
2022 Q4	$207K	Sell	4,593 -2,294	-33%	-$79K	0.01%	713
2022 Q3	$204K	Buy	+6,887	New	+$193K	0.01%	721

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Quadrature Capital's SMTI Position: Q1 2026 in Review

Quadrature Capital opened a new position in Sanara MedTech (SMTI) in Q1 2026: 10,172 shares worth $175K. The stake represents ﹤0.01% of the portfolio and ranks #1148 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in SMTI as recently as Q1 2024.

Quadrature Capital first reported a position in SMTI in Q3 2022 and has held it in 8 quarters since. The position peaked at $694K in Q2 2023. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

Quadrature Capital held 10,172 shares of Sanara MedTech worth $175K as of Q1 2026.
Sanara MedTech was a new Quadrature Capital position in Q1 2026.
Sanara MedTech made up ﹤0.01% of Quadrature Capital's portfolio in Q1 2026, its #1148 holding.
Quadrature Capital first reported a position in Sanara MedTech in Q3 2022 and has held it in 8 quarters since.
Quadrature Capital's Sanara MedTech position peaked at $694K in Q2 2023.
65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.